#Madrid #Italy #Esaote Group #MyLab C30 #HeartScan Assistant

Esaote Group to Present Innovations in Cardiology at ESC 2025

Esaote Group, a top Italian innovator in medical imaging, will showcase its latest advancements in cardiology at the European Society of Cardiology (ESC) Congress 2025 happening from August 29 to September 1 at IFEMA Madrid (Booth A280, Exhibition Hall West). This event is poised to highlight Esaote's commitment to enhancing diagnostic accuracy and clinical decision-making in the cardiovascular realm.

At the heart of Esaote's presentation is the MyLab™C30 cardio, a powerful portable ultrasound system designed specifically for cardiology. It features the largest touchscreen in its class, delivering an intuitive interface alongside advanced AI capabilities. This state-of-the-art device significantly reduces examination time while ensuring diagnostic confidence, even in the most complex cases, thus providing reliable quantitative and qualitative assessments. Its long battery life and robust performance make it an ideal choice for routine and emergency situations.

Additionally, Esaote introduces the HeartScan Assistant, a new AI-enabled function that streamlines cardiac ultrasound procedures. This innovative tool assists healthcare professionals in acquiring transthoracic cardiac images by providing real-time feedback on view classification and image quality. This not only accelerates the daily practice of cardiologists but also proves particularly beneficial in emergency care settings and for less experienced practitioners.

A highlight of the event will be a detailed presentation on Hyperdoppler techniques and their clinical applications, scheduled for Saturday, August 30, from 12:00 to 13:30 at Esaote's booth. This session aims to demonstrate how force distribution analysis can identify dilated or dysfunctional hearts and monitor the effects of resynchronization therapies in heart failure patients.

On the health IT front, Ebit, Esaote’s health IT subsidiary will unveil the latest evolution of its Suitestensa CVIS PACS platform tailored for outpatient and interventional cardiology. Integrating AI-driven tools such as fAInd for clinical decision support and ZEfiRO for intelligent workflow orchestration, this platform ensures seamless compatibility with advanced tools like CAAS Qardia.

The CAAS Qardia, developed by Pie Medical Imaging (part of Esaote Group), is a specialized echocardiography suite. The upcoming version 2.2, which will be showcased at the ESC, introduces the Qardia View Classifier. This AI-driven assistant pre-selects the optimal images for standardized measurements, minimizing manual selection and reducing time spent navigating image sets. Furthermore, critical echo measurements such as myocardial strain and heart dimensions are now automated, offering clutter-free and autonomous web-browser access.

Esaote Group remains unwavering in its dedication to advancing cardiovascular diagnostics through continuous innovation, clinical collaboration, and investment in research and development.

Pending FDA approval. Not available for sale in the United States.

Esaote Group stands as a leader in the field of medical imaging, including ultrasound, MRI, and diagnostic process management software. By the end of 2024, the group employed around 1,300 individuals, with a significant portion based in Italy. With manufacturing and R&D facilities located in Genoa and Florence, and operations in over 100 countries worldwide, Esaote continues to make its mark on the global healthcare landscape. Visit www.esaote.com for more information.